|
1
|
Committee of Experts of the Chinese
Society of Clinical Oncology for Melanoma, . China melanoma
treatment guidelines (2011). Chin Clin Oncol. 159–171. 2012.
|
|
2
|
Balch CM, Soong SJ, Gershenwald JE, et al:
Prognostic factors analysis of 17,600 melanoma patients: validation
of the American Joint Committee on Cancer melanoma staging system.
J Clin Oncol. 19:3622–3634. 2001.PubMed/NCBI
|
|
3
|
Kivelä T, Eskelin S, Mäkitie T and
Summanen P: Exudative retinal detachment from malignant uveal
melanoma: predictors and prognostic significance. Invest Ophthalmol
Vis Sci. 42:2085–2093. 2001.PubMed/NCBI
|
|
4
|
Yang XY, Xie F, Tao R, Li AJ and Wu MC:
Treatment of liver metastases from uveal melanoma: a retrospective
single-center analysis. Hepatobiliary Pancreat Dis Int. 12:602–606.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rivoire M, Kodjikian L, Baldo S,
Kaemmerlen P, Négrier S and Grange JD: Treatment of liver
metastases from uveal melanoma. Ann Surg Oncol. 12:422–428. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rietschel P, Panageas KS, Hanlon C, Patel
A, Abramson DH and Chapman PB: Variates of survival in metastatic
uveal melanoma. J Clin Oncol. 23:8076–8080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Varghese S, Xu H, Bartlett D, et al:
Isolated hepatic perfusion with high-dose melphalan results in
immediate alterations in tumor gene expression in patients with
metastatic ocular melanoma. Ann Surg Oncol. 17:1870–1877. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peters S, Voelter V, Zografos L, et al:
Intra-arterial hepatic fotemustine for the treatment of liver
metastases from uveal melanoma: experience in 101 patients. Ann
Oncol. 17:578–583. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rubio S, Barbero-Villares A, Reina T,
Nieto S, Mendoza J and García-Buey L: Rapidly-progressive liver
failure secondary to melanoma infiltration. Gastroenterol Hepatol.
28:619–621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chun HJ, Osuga K, Fahrni M and Nakamura H:
Massive bleeding of ruptured metastatic hepatic melanoma treated by
transarterial embolization. Jpn J Radiol. 28:395–397. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wagner WH, Lundell CJ and Donovan AJ:
Percutaneous angiographic embolization for hepatic arterial
hemorrhage. Arch Surg. 120:1241–1249. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cooperman AM, Weiland LH and Welch JS:
Massive bleeding from a ruptured metastatic hepatic melanoma
treated by hepatic lobectomy. Case report and review of the
literature. Mayo Clin Proc. 51:167–170. 1976.PubMed/NCBI
|
|
13
|
Papastefanou VP and Cohen VM: Uveal
melanoma. J Skin Cancer. 2011:5739742011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyamoto C, Balazsi M, Bakalian S,
Fernandes BF and Burnier MN Jr: Uveal melanoma: Ocular and systemic
disease. Saudi J Ophthalmol. 26:145–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Materin MA, Faries M and Kluger HM:
Molecular alternations in uveal melanoma. Curr Probl Cancer.
35:211–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang C and Wei W: The miRNA expression
profile of the uveal melanoma. Sci China Life Sci. 54:351–358.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sisley K, Doherty R and Cross NA: What
hope for the future? GNAQ and uveal melanoma. Br J Ophthalmol.
95:620–623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rajpal S, Moore R and Karakousis CP:
Survival in metastatic ocular melanoma. Cancer. 52:334–336. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crowley NJ and Seigler HF: Late recurrence
of malignant melanoma. Analysis of 168 patients. Ann Surg.
212:173–177. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pons F, Plana M, Caminal JM, et al:
Metastatic uveal melanoma: is there a role for conventional
chemotherapy? - A single center study based on 58 patients.
Melanoma Res. 21:217–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hameed AM, Ng EE, Johnston E, et al:
Hepatic resection for metastatic melanoma: a systematic review.
Melanoma Res. 24:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Triozzi PL and Singh AD: Blood biomarkers
of uveal melanoma metastasis. Br J Ophthalmol. 95:3–4. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Augsburger JJ, Corrêa ZM and Shaikh AH:
Effectiveness of treatments for metastatic uveal melanoma. Am J
Ophthalmol. 148:119–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vahrmeijer AL, van de Velde CJ, Hartgrink
HH and Tollenaar RA: Treatment of melanoma metastases confined to
the liver and future perspectives. Dig Surg. 25:467–472. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mariani P, Piperno-Neumann S, Servois V,
et al: Surgical management of liver metastases from uveal melanoma:
16 years' experience at the Institut Curie. Eur J Surg Oncol.
35:1192–1197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aubin JM, Rekman J, Vandenbroucke-Menu F,
et al: Systematic review and meta-analysis of liver resection for
metastatic melanoma. Br J Surg. 100:1138–1147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao J, Yan LN and Li B: Adult-to-adult
living donor liver transplantation for malignant metastatic
melanoma to the liver. Hepatobiliary Pancreat Dis Int. 9:329–332.
2010.PubMed/NCBI
|
|
28
|
You MX, Yu XX, Wu K, Lin YS, Zhu GQ and
Shi CS: Analysis of risk factors for spontaneous rupture of
hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi. 35:217–220.
2013.(In Chinese). PubMed/NCBI
|
